| Primary |
| Pneumonia |
14.4% |
| Product Used For Unknown Indication |
11.4% |
| Bronchitis |
11.0% |
| Urinary Tract Infection |
7.6% |
| Acute Sinusitis |
5.7% |
| Cataract Operation |
4.9% |
| Nasopharyngitis |
4.2% |
| Conjunctival Hyperaemia |
3.8% |
| Corneal Epithelium Defect |
3.8% |
| Cystitis |
3.8% |
| Diabetes Mellitus |
3.8% |
| Mycobacterial Infection |
3.8% |
| Pharyngitis |
3.4% |
| Rhinitis Allergic |
3.0% |
| Sinusitis |
3.0% |
| Type 2 Diabetes Mellitus |
3.0% |
| Corneal Opacity |
2.7% |
| Cellulitis |
2.3% |
| Infection |
2.3% |
| Bronchitis Acute |
1.9% |
|
| Hypoglycaemia |
45.8% |
| Hyperglycaemia |
9.9% |
| Anaphylactic Shock |
4.2% |
| Loss Of Consciousness |
3.5% |
| Pyrexia |
3.5% |
| Renal Failure |
3.5% |
| Blood Glucose Increased |
2.8% |
| Diarrhoea |
2.8% |
| Hypoglycaemic Coma |
2.8% |
| Thrombocytopenia |
2.8% |
| Anaphylactic Reaction |
2.1% |
| Cough |
2.1% |
| Drug Eruption |
2.1% |
| Pupillary Reflex Impaired |
2.1% |
| Rhabdomyolysis |
2.1% |
| Shock |
2.1% |
| Agranulocytosis |
1.4% |
| Clostridium Colitis |
1.4% |
| Convulsion |
1.4% |
| Corneal Perforation |
1.4% |
|
| Secondary |
| Product Used For Unknown Indication |
16.0% |
| Pharyngitis |
7.2% |
| Arthritis Infective |
7.0% |
| Gastrointestinal Infection |
7.0% |
| Genitourinary Tract Infection |
7.0% |
| Osteomyelitis |
7.0% |
| Respiratory Tract Infection |
7.0% |
| Skin Infection |
7.0% |
| Rhinitis Allergic |
5.7% |
| Acute Sinusitis |
5.0% |
| Conjunctival Hyperaemia |
3.3% |
| Corneal Epithelium Defect |
3.3% |
| Cough |
3.2% |
| Drug Use For Unknown Indication |
2.7% |
| Urethritis |
2.7% |
| Corneal Opacity |
2.3% |
| Pneumonia |
2.3% |
| Bronchopneumonia |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Ocular Hyperaemia |
1.3% |
|
| Neuropathy Peripheral |
13.8% |
| Renal Failure Acute |
12.3% |
| Anaphylactic Shock |
9.2% |
| Drug Hypersensitivity |
6.2% |
| Electrocardiogram Qt Prolonged |
6.2% |
| Interstitial Lung Disease |
6.2% |
| Vitreous Opacities |
6.2% |
| Osteoarthritis |
4.6% |
| Agranulocytosis |
3.1% |
| Corneal Disorder |
3.1% |
| Hepatic Function Abnormal |
3.1% |
| Hyperglycaemia |
3.1% |
| Hypermetropia |
3.1% |
| Paranoia |
3.1% |
| Prostate Infection |
3.1% |
| Rash |
3.1% |
| Vision Blurred |
3.1% |
| Visual Acuity Reduced |
3.1% |
| White Blood Cell Count Increased |
3.1% |
| Blood Glucose Increased |
1.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
35.2% |
| Drug Use For Unknown Indication |
25.3% |
| Macular Degeneration |
8.6% |
| Age-related Macular Degeneration |
5.5% |
| Hypertension |
3.2% |
| Multiple Myeloma |
2.8% |
| Prophylaxis |
2.5% |
| Retinal Detachment |
2.1% |
| Transient Ischaemic Attack |
1.6% |
| Ulcerative Keratitis |
1.5% |
| Insomnia |
1.4% |
| Acute Myeloid Leukaemia |
1.3% |
| Depression |
1.3% |
| Diabetic Retinal Oedema |
1.3% |
| Bronchitis |
1.2% |
| Hypercalcaemia |
1.1% |
| Chronic Obstructive Pulmonary Disease |
1.0% |
| Rheumatoid Arthritis |
1.0% |
| Central Nervous System Inflammation |
0.9% |
| Cns Ventriculitis |
0.9% |
|
| Retinal Pigment Epithelial Tear |
19.6% |
| Visual Acuity Reduced |
10.1% |
| Vitreous Haemorrhage |
7.1% |
| Cerebral Infarction |
6.5% |
| Endophthalmitis |
6.0% |
| Retinal Haemorrhage |
6.0% |
| Wheezing |
5.4% |
| Vascular Graft |
4.8% |
| Keratitis |
4.2% |
| Myocardial Infarction |
3.6% |
| Neuropathy Peripheral |
3.6% |
| Rhabdomyolysis |
3.6% |
| Intraocular Pressure Increased |
3.0% |
| Choroidal Dystrophy |
2.4% |
| Inappropriate Schedule Of Drug Administration |
2.4% |
| Post Procedural Complication |
2.4% |
| Pseudoendophthalmitis |
2.4% |
| Retinal Detachment |
2.4% |
| Tachycardia |
2.4% |
| Thrombocytopenia |
2.4% |
|
| Interacting |
| Cardiac Disorder |
29.4% |
| Eye Operation |
17.6% |
| Aortic Valve Replacement |
5.9% |
| Asthma |
5.9% |
| Increased Upper Airway Secretion |
5.9% |
| Infection |
5.9% |
| Neuralgia |
5.9% |
| Pneumonia |
5.9% |
| Product Used For Unknown Indication |
5.9% |
| Prophylaxis |
5.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
5.9% |
|
| Eye Operation |
33.3% |
| Prothrombin Time Prolonged |
33.3% |
| Vomiting |
33.3% |
|
